0.68 - 0.75
0.33 - 0.86
13.06M / 4.66M (Avg.)
34.50 | 0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-25.95%
Negative revenue growth while 3606.HK stands at 2.30%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-48.58%
Negative gross profit growth while 3606.HK is at 2.37%. Joel Greenblatt would examine cost competitiveness or demand decline.
-122.15%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-122.15%
Negative operating income growth while 3606.HK is at 2.67%. Joel Greenblatt would press for urgent turnaround measures.
-112.71%
Negative net income growth while 3606.HK stands at 6.87%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-111.92%
Negative EPS growth while 3606.HK is at 5.88%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-111.92%
Negative diluted EPS growth while 3606.HK is at 5.88%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
5.84%
Share change of 5.84% while 3606.HK is at zero. Bruce Berkowitz would see if slight buybacks (or dilution) matter in the bigger picture.
5.85%
Diluted share change of 5.85% while 3606.HK is zero. Bruce Berkowitz might see a minor difference that could widen over time.
-1.18%
Dividend reduction while 3606.HK stands at 1216.65%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
21.66%
Positive OCF growth while 3606.HK is negative. John Neff would see this as a clear operational advantage vs. the competitor.
22.08%
Positive FCF growth while 3606.HK is negative. John Neff would see a strong competitive edge in net cash generation.
-40.24%
Negative 10Y revenue/share CAGR while 3606.HK stands at 88.97%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-52.05%
Negative 5Y CAGR while 3606.HK stands at 43.74%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
20.63%
3Y revenue/share CAGR above 1.5x 3606.HK's 8.39%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
-6853.77%
Negative 10Y OCF/share CAGR while 3606.HK stands at 0.00%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
-29.54%
Negative 5Y OCF/share CAGR while 3606.HK is at 66.65%. Joel Greenblatt would question the firm’s operational model or cost structure.
-75.23%
Negative 3Y OCF/share CAGR while 3606.HK stands at 1.02%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
-114.02%
Negative 10Y net income/share CAGR while 3606.HK is at 81.68%. Joel Greenblatt sees a major red flag in long-term profit erosion.
-118.06%
Negative 5Y net income/share CAGR while 3606.HK is 3.48%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-148.19%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
90.48%
Below 50% of 3606.HK's 255.76%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
-2.50%
Negative 5Y equity/share growth while 3606.HK is at 53.53%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
38.48%
3Y equity/share CAGR 1.25-1.5x 3606.HK's 30.17%. Bruce Berkowitz confirms timely buybacks or margin improvements drive stronger near-term equity growth.
-24.01%
Both reduced dividends long-term. Martin Whitman might check if sector-level headwinds forced universal cuts.
-60.78%
Both lowered dividends mid-term. Martin Whitman might suspect broad sector constraints or strategic shifts from dividends.
-60.06%
Both firms reduced dividends recently. Martin Whitman suspects broader macro or industry issues forcing cost and payout cuts.
-20.45%
Firm’s AR is declining while 3606.HK shows 1.94%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
6.44%
Inventory growth well above 3606.HK's 4.17%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
-4.93%
Negative asset growth while 3606.HK invests at 11.02%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
8.83%
75-90% of 3606.HK's 10.77%. Bill Ackman advocates improvements in profitability or buybacks to keep pace in net worth growth.
7.92%
Debt growth far above 3606.HK's 3.51%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.
15.24%
R&D growth drastically higher vs. 3606.HK's 0.18%. Michael Burry fears near-term margin erosion unless breakthroughs are imminent.
-27.52%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.